Dr. Michael Boyle is an Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine, and President and CEO of the U.S. Cystic Fibrosis Foundation. His areas of expertise include adult cystic fibrosis care and research. Dr. Boyle founded and directed the Johns Hopkins Adult Cystic Fibrosis Program from 1999 to 2015 at the Johns Hopkins Cystic Fibrosis Center. Dr. Boyle completed all of his medical training at Johns Hopkins including fellowship in pulmonary and critical care medicine before joining the Johns Hopkins faculty in 1999. He is internationally known both for his clinical research in CFTR modulators and for his work to improve care for adults with cystic fibrosis. While at Johns Hopkins he has received numerous honors including the American Lung Association’s George Comstock Career Achievement Award, American Federation of Clinical Research Achievement Award, “Patient’s Choice Award”, “Best Full-Time Faculty Teacher”, and “Best Doctors in America”.